Bovie Medical Insights

Turkey Can Make the Grade for Good

Posted by Bovie Medical on Tue, Nov 20, 2012 @ 03:52 PM

ID 10086297For the first time in nearly two decades Turkey secured its first investment-grade credit rating.  While you won't mistake Germany for Turkey, none the less, with all the challenges facing the European Union, I think it is quite interesting that Turkey and Bulgaria are doing pretty darn good.  Is there a lesson here?

Following is an article from the Wall Street Journal, Turkey Can Make the Grade for Good

"November isn't usually a great month for turkeys. But for the country Turkey, it couldn't have started any better: ratings firm Fitch has upgraded its sovereign debt to investment grade for the first time. The move caused yields on Turkey's two-year bonds to fall by 0.25 percentage point and Turkey's stock market to rise 1.8% on Monday. Still, the excitement may not prove lasting—if only because investors are already ahead of ratings firms in seeing Turkey as a safer bet than some of its more vaunted European peers.

Fitch's move looks justified based on Turkey's fiscal position. Its level of debt to GDP should fall to 37% by the end of 2012, Fitch estimates—far lower than the 87% average for euro-zone countries last year. The average maturity of its debt has increased to 4.5 years from 3.5 years in 2009. Since the Turkish lira's 40% devaluation in 2001, Turkey's economy has proved reasonably stable, though it did contract 4.8% in 2009. The Fitch upgrade should help create a virtuous loop of greater investor confidence: Credit default swaps on its five-year bonds have been trading at a far lower premium than countries like Italy and Spain for some time.

Still, Turkey isn't without vulnerabilities, including inflation running at 7.8%. Its current-account deficit remains high, though it is expected to narrow to 7.3% of GDP in 2012 from 10% in 2011. Its banking system, meanwhile, is reliant on external funding due to a low savings rate. Banks' short-term external debt has doubled to around $70 billion, or 9% of GDP, in the past two years, according to Capital Economics. Sudden capital flight due to, say, a worsening euro-zone crisis would leave Turkey's banks short of money to lend, hitting growth hard."

Continue reading the full article here.

 

Rob Saron Signature

 

 

J. Robert Saron
President
Bovie Medical Corporation

 

J-Plasma and Electrosurgery

 

 Like what you've read? Click here to subscribe to this blog.

 

Image courtesy of creativedoxfoto / FreeDigitalPhotos.net

Topics: Rob Saron, Wall Street Journal Article, Turkey, Germany, European Union

Follow Us

Subscribe to our Blog

Free Resources
Understanding Cryosurgery for Simple Skin Procedures
White-Paper: J-Plasma Study 12-2014 

Screen shot 2011-09-08 at 5.20.16 PM

J-Plasma: Your Questions Answered

Surgical Smoke in OR  

 

<<View Additional Resources>>

Latest Posts